Literature DB >> 12794445

Counterintuitive red blood cell substitute--polyethylene glycol-modified human hemoglobin.

George C Kramer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12794445     DOI： 10.1097/01.CCM.0000069341.90159.C7

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  3 in total

Review 1.  Nanomedicine: clinical applications of polyethylene glycol conjugated proteins and drugs.

Authors:  Suphiya Parveen; Sanjeeb K Sahoo
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

2.  Influence of intramolecular cross-links on the molecular, structural and functional properties of PEGylated haemoglobin.

Authors:  Tao Hu; Belur N Manjula; Dongxia Li; Michael Brenowitz; Seetharama A Acharya
Journal:  Biochem J       Date:  2007-02-15       Impact factor: 3.857

3.  Effects of maleimide-polyethylene glycol-modified human hemoglobin (MP4) on tissue necrosis in SKH1-hr hairless mice.

Authors:  Ole Goertz; M H Kirschner; H Lilienfein; P Babilas; H U Steinau; C Andree; A Daigeler; A Stachon; H Homann; S Langer
Journal:  Eur J Med Res       Date:  2009-03-17       Impact factor: 2.175
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.